On TV.com: ANGELINA JOLIE looks stunning as usual
Find Articles in:
all
Business
Reference
Technology
News
Sports
Health
Autos
Arts
Home & Garden
advertisement
advertisement

Content provided in partnership with
Thomson / Gale

Trinity Biotech plc to Announce Second Quarter 2008 Financial Results on July 21, 2008

PR Newswire,  July 15, 2008  

Conference Call Scheduled for July 22, 2008 at 11:00 am EASTERN

DUBLIN, Ireland, July 15 /PRNewswire-FirstCall/ -- Trinity Biotech plc , a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter of fiscal year 2008 on Tuesday, July 22, 2008. The Company has scheduled a conference call for that same day, Tuesday, July 22, 2008, at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.

  Interested parties can access the call by dialing:
   USA:             877-356-5706
   International:   +1-706-643-0580


A simultaneous webcast of the call can be accessed at: http://www.videonewswire.com/event.asp?id=50024

  A replay of the call can be accessed until July 25, 2008 by dialing:

  USA:               1-800-642-1687
  International:     +1-706-645-9291
  Conference ID #:   56210288


The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=50024

About Trinity Biotech plc

Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires, manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.

For further information please see the company's website: http://www.trinitybiotech.com/.

  Contact:
  Ms. Niamh Long                Joe Diaz, Joe Dorame and Robert Blum
  Trinity Biotech plc           Lytham Partners, LLC
  Investor Relations Officer    602-889-7900
  (800) 603-8076

CONTACT: Ms. Niamh Long Investor Relations Officer, Trinity Biotech plc, 1-800-603-8076; or Joe Diaz, Joe Dorame and Robert Blum, all of Lytham Partners, LLC, +1-602-889-7900, for Trinity Biotech plc

Web site: http://www.trinitybiotech.com/

COPYRIGHT 2008 PR Newswire Association LLC
COPYRIGHT 2008 Gale, Cengage Learning